ReviewExploration (Beijing, China)2026
Biosensing With Nanofluidics.
Review in Exploration (Beijing, China), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nanofluidics for Pioneering Synthetic Biology of Bottom-Up Cell-Free Molecular Systems.ACS synthetic biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nanofluidics, the study of fluid transport confined within nanochannels and nanopores, has emerged as a transformative technology across various domains, including sensing, separation, energy harvesting, materials synthesis, and bionic systems. Biosensing with nanofluidics, which involves the conversion of biomolecular information into fluidic signals through nanoscale fluid manipulation, is on the verge of revolutionizing the sensing paradigm, from DNA/protein sequencing, single-molecule analysis, disease diagnosis, and precision medicine. In this review, we provide an overview of the current progress in nanofluidic biosensing, with a focus on in-plane, out-of-plane, and free-plane nanochannel and nanopore structures. We highlight the potential of nanofluidics in biosensing applications and discuss the current challenges faced in the development of nanofluidic-based biosensing technologies. Furthermore, we explore future opportunities in this field, propose potential solutions to these challenges, and aim to contribute to the ongoing discourse in nanofluidic biosensing. Our insights are intended to pave the way for future advancements in this promising field.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.